Literature DB >> 23504273

Systematic study of human long intergenic non-coding RNAs and their impact on cancer.

Liang Sun1, Haitao Luo, Qi Liao, Dechao Bu, Guoguang Zhao, Changning Liu, Yuanning Liu, Yi Zhao.   

Abstract

The functional impact of several long intergenic non-coding RNAs (lincRNAs) has been characterized in previous studies. However, it is difficult to identify lincRNAs on a large-scale and to ascertain their functions or predict their structures in laboratory experiments because of the diversity, lack of knowledge and specificity of expression of lincRNAs. Furthermore, although there are a few well-characterized examples of lincRNAs associated with cancers, these are just the tip of the iceberg owing to the complexity of cancer. Here, by combining RNA-Seq data from several kinds of human cell lines with chromatin-state maps and human expressed sequence tags, we successfully identified more than 3000 human lincRNAs, most of which were new ones. Subsequently, we predicted the functions of 105 lincRNAs based on a coding-non-coding gene co-expression network. Finally, we propose a genetic mediator and key regulator model to unveil the subtle relationships between lincRNAs and lung cancer. Twelve lincRNAs may be principal players in lung tumorigenesis. The present study combines large-scale identification and functional prediction of human lincRNAs, and is a pioneering work in characterizing cancer-associated lincRNAs by bioinformatics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23504273     DOI: 10.1007/s11427-013-4460-x

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  16 in total

1.  Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression.

Authors:  Wen-Qin Zhou; Peng Wang; Qiu-Ping Shao; Jian Wang
Journal:  Mol Cell Biochem       Date:  2016-07-08       Impact factor: 3.396

Review 2.  LncRNAs: key players and novel insights into cervical cancer.

Authors:  Li Peng; Xiaoqing Yuan; Binyuan Jiang; Zaili Tang; Guan-Cheng Li
Journal:  Tumour Biol       Date:  2015-12-29

3.  LncDisease: a sequence based bioinformatics tool for predicting lncRNA-disease associations.

Authors:  Junyi Wang; Ruixia Ma; Wei Ma; Ji Chen; Jichun Yang; Yaguang Xi; Qinghua Cui
Journal:  Nucleic Acids Res       Date:  2016-02-16       Impact factor: 16.971

4.  Chromosome preference of disease genes and vectorization for the prediction of non-coding disease genes.

Authors:  Hui Peng; Chaowang Lan; Yuansheng Liu; Tao Liu; Michael Blumenstein; Jinyan Li
Journal:  Oncotarget       Date:  2017-08-24

5.  Comprehensive characterization of 10,571 mouse large intergenic noncoding RNAs from whole transcriptome sequencing.

Authors:  Haitao Luo; Silong Sun; Ping Li; Dechao Bu; Haiming Cao; Yi Zhao
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 6.  Genomic-Wide Analysis with Microarrays in Human Oncology.

Authors:  Kenichi Inaoka; Yoshikuni Inokawa; Shuji Nomoto
Journal:  Microarrays (Basel)       Date:  2015-10-16

7.  FMLNCSIM: fuzzy measure-based lncRNA functional similarity calculation model.

Authors:  Xing Chen; Yu-An Huang; Xue-Song Wang; Zhu-Hong You; Keith C C Chan
Journal:  Oncotarget       Date:  2016-07-19

Review 8.  Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer.

Authors:  Yancheng Zhong; Dan Gao; Shiwei He; Cijun Shuai; Shuping Peng
Journal:  Int J Gynecol Cancer       Date:  2016-11       Impact factor: 3.437

9.  Genome-Wide Identification and Characterization of Long Non-Coding RNAs from Mulberry (Morus notabilis) RNA-seq Data.

Authors:  Xiaobo Song; Liang Sun; Haitao Luo; Qingguo Ma; Yi Zhao; Dong Pei
Journal:  Genes (Basel)       Date:  2016-02-29       Impact factor: 4.096

10.  ILNCSIM: improved lncRNA functional similarity calculation model.

Authors:  Yu-An Huang; Xing Chen; Zhu-Hong You; De-Shuang Huang; Keith C C Chan
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.